Santarus, Inc. - SWOT Analysis

Santarus, Inc. - SWOT Analysis
  • Report price : $ 125
  • Publication date : October 2007
  • Length : 20 pages

Get this Report Now !

Santarus, Inc. - SWOT Analysis

Datamonitor's Santarus, Inc. SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Santarus is a specialty pharmaceutical company focused on acquiring, developing and commercializing products for patients with gastrointestinal diseases and disorders. The company is headquartered in San Diego, California and employs approximately 340 people. The company recorded revenues of $49.2 million during the fiscal year ended December 2006, an increase of 85.7% over 2005. The operating loss of the company was $ 59.5 million during fiscal year 2006, as compared to an operating loss of $69.7 million in 2005. The net loss was $56.5 million in fiscal year 2006, as compared to a net loss of $65 million in 2005.

Scope of the Report

- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available

RELATED REPORTS

Commercial and Pipeline Insight: Infertility - Optimizing a market bounded by social opinion and physician preference

Commercial and Pipeline Insight: Infertility - Optimizing a market bounded by social opinion and physician preference

  • $ 15 200
  • October 2007
  • 189 pages

IntroductionThe market for infertility drugs is a complex and dynamic arena shaped by numerous factors such as changing social attitudes, national legislation, and prescriber preferences. Brand strength and diverse portfolios have allowed Organon, Merck Serono and Ferring to secure a firm foothold i ...

Industries : Pharmaceutical | Countries : USA, Japan, Germany, Spain, France, Italy

Actelion: PharmaVitae Profile

Actelion: PharmaVitae Profile

  • $ 5 700
  • October 2007
  • 108 pages

IntroductionThis analysis examines the historical and forecast performance for Actelion in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An inte ...

Industries : Pharmaceutical | Countries : USA

Roche: PharmaVitae Profile

Roche: PharmaVitae Profile

  • $ 5 700
  • October 2007
  • 187 pages

IntroductionThis analysis examines the historical and forecast performance for Roche in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interac ...

Industries : Pharmaceutical | Countries : USA, Japan

Chugai: PharmaVitae Profile 2007

Chugai: PharmaVitae Profile 2007

  • $ 5 700
  • October 2007
  • 158 pages

IntroductionThis analysis examines the historical and forecast performance for Chugai in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An intera ...

Industries : Pharmaceutical | Countries : USA, Japan

Genentech: PharmaVitae Profile

Genentech: PharmaVitae Profile

  • $ 5 700
  • October 2007
  • 171 pages

IntroductionThis analysis examines the historical and forecast performance for Genentech in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An int ...

Industries : Pharmaceutical | Countries : USA, Croatia

Endo Pharmaceuticals Holdings Inc. - SWOT Analysis

Endo Pharmaceuticals Holdings Inc. - SWOT Analysis

  • $ 125
  • October 2007
  • 20 pages

Datamonitor's Endo Pharmaceuticals Holdings Inc. SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strate ...

Industries : Pharmaceutical | Countries : USA

ALK-Abello - SWOT Analysis

ALK-Abello - SWOT Analysis

  • $ 125
  • October 2007
  • 20 pages

Datamonitor's ALK-Abello SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. ALK-Abello is a Denm ...

Industries : Pharmaceutical | Countries : USA, Denmark

Integra LifeSciences Holdings Corp - SWOT Analysis

Integra LifeSciences Holdings Corp - SWOT Analysis

  • $ 125
  • October 2007
  • 20 pages

Datamonitor's Integra LifeSciences Holdings Corp SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strate ...

Industries : Pharmaceutical | Countries : USA

Enzon Pharmaceuticals, Inc. - SWOT Analysis

Enzon Pharmaceuticals, Inc. - SWOT Analysis

  • $ 125
  • October 2007
  • 20 pages

Datamonitor's Enzon Pharmaceuticals, Inc. SWOT company profile is the essential source for top-level company data and information. The report examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Enz ...

Industries : Pharmaceutical | Countries : USA

The Licensing Agreement in Pharmaceutical Business Development: 3rd edition

The Licensing Agreement in Pharmaceutical Business Development: 3rd edition

  • $ 875
  • July 2007
  • 60 pages

Pharmalicensing's best selling licensing report has returned, fully revised and updated with new statistics, data and expert advice.Licensing is at it's peak - in-licensed products now generate over 30% of the revenues of the major pharmaceutical companies and some 25% of the ‘blockbusters’ of ...

Industries : Pharmaceutical | Countries : USA

reportlinker.com © Copyright 2009. All rights reserved

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.